Seven Million Patients. Still Falling Through the Gaps
I was in a clinic in Riyadh last year when a physician pulled up a patient's record and paused. The patient, a 54-year-old with a twelve-year history of Type 2 diabetes, had just been referred from a primary care centre across the city. The referral note said "poorly controlled." The record said almost nothing else. No HbA1c trend. No medication history. No record of whether he had ever seen an ophthalmologist or a nephrologist.
"I'm starting from scratch," the physician said. "Again."
That word, again, carried a lot of weight.
The scale of the problem
Saudi Arabia ranks among the top ten countries in the world for diabetes prevalence, with nearly 7 million diabetic and 3 million pre-diabetic patients, costing around 13.9% of total health expenditure in the Kingdom. According to the Health Sector Transformation Program, the number of diabetes patients in Saudi Arabia is expected to reach 8.4 million by 2030.
Those are familiar statistics. What gets less attention is what happens to those patients once they are diagnosed. Studies across five administrative regions of the Kingdom found that 77% of Type 2 diabetes patients had uncontrolled diabetes. Not newly diagnosed. Not untreated. Uncontrolled, despite being in the system.
That is not a clinical failure. It is a system failure.
What uncontrolled actually means
When we say a patient's diabetes is uncontrolled, we mean their condition is progressing toward complications that are expensive, irreversible, and entirely predictable. Kidney disease. Cardiovascular events. Neuropathy. Retinopathy. Research on the economic burden of diabetes in Saudi Arabia estimates average incremental cost savings of $38,878 per diabetic patient when complications are prevented, including $11,108 in the year of complication onset alone.
Prevention is not just the right clinical outcome. It is the dramatically cheaper one. A healthcare system that fails to manage diabetes longitudinally does not save money by avoiding the cost of follow-up. It accumulates a far larger bill downstream, paid in emergency admissions, dialysis, and cardiovascular procedures.
The chronic disease burden in the Kingdom is precisely why Vision 2030's shift toward prevention and population health management matters so much. But shifting to prevention requires something the current system often cannot provide: a continuous, unbroken view of the patient over time.
Why Follow-Up Fails
A diabetic patient in Saudi Arabia may interact with a government primary care centre, a Ministry of Health hospital, a private clinic, and a specialist facility across the course of a year. Each of those touchpoints likely runs a different system. None of them automatically share information. The HbA1c test done at one facility does not automatically appear at the next. The medication change made by the endocrinologist is not visible to the GP who sees the patient three months later for something unrelated.
This lack of interoperability creates formidable challenges for healthcare providers, leading to incomplete patient histories, missing medications, and duplicate visits when patients transfer between facilities.
For a patient with a condition that requires consistent monitoring over years, this fragmentation is not a minor inconvenience. It means that every new clinician who sees them is making decisions with incomplete information. It means that deteriorating trends in blood glucose or kidney function can go unnoticed simply because no single clinician has visibility across the patient's full journey. It means that the window for intervention, the moment when a complication can still be prevented, quietly closes.
Why the data exists but does not connect
This is not a problem of data scarcity. Saudi Arabia generates enormous volumes of clinical data every day. NPHIES was built precisely to address this, creating a national platform for health information exchange that connects hospitals, insurers, and providers. The ambition is exactly right.
But a platform that enables data exchange is not the same as a platform that enables population health management. Knowing that a patient visited three facilities this year is not the same as understanding their longitudinal risk trajectory, identifying that their HbA1c has risen consistently over eighteen months, or triggering a proactive outreach before the complication occurs.
The technology to do this exists. The data to power it is being generated. The gap is in the intelligence layer that sits between the data and the clinical decision: the ability to identify which patients are drifting toward a crisis, and act before that crisis arrives.
What managing chronic disease at scale actually requires
The countries that have made genuine progress on chronic disease outcomes share a common infrastructure: unified longitudinal patient records, risk stratification that identifies high-risk patients before they deteriorate, and care coordination workflows that ensure no patient falls silently through the gaps between appointments.
None of this requires a new hospital. It requires the data that already exists to be connected, analysed, and acted on systematically. It requires primary care teams to have a dashboard that shows them which of their diabetic patients have not had an HbA1c check in six months, which ones have a rising cardiovascular risk score, and which ones stopped filling their prescriptions.
That is population health management. It is not a futuristic concept. It is operational today in health systems that have made the commitment.
Saudi Arabia has 8 million reasons to make that commitment. The patients are already in the system. The question is whether the system can see them clearly enough to keep them well.
